Prescribing and Community Pharmacy updates
- Updated Medicines Delivery Service during COVID-19 outbreak letter (11/01/2021)
- Medicines Delivery Service during COVID-19 outbreak letter (04/01/2021)
- Medicine Supply Notification - Trifluoperazine 1mg/5ml syrup (Advanz Pharma) (11/11/2020)
- Medicine Supply Notification - Dulcolax® (bisacodyl) 5mg and 10mg suppositories (11/1/1/2020)
- Declaration of Equivalence between common layout English-French-Arabic (EFA) and the layout of the reference country United Kingdom (UK) for the medicinal product Konakion 2mg/0.2ml (22/10/2020)
- Current situation regarding KONAKION SOL FOR INJ AMP 2MG/0.2ML (2mg phytomenadione in 0.2ml) (22/10/2020)
- Medicine Supply Notification - Salazopyrin En-Tabs® (sulfasalazine) 500mg tablets (22/10/2020)
- Medicine Supply Notification - Fluoxetine 30mg capsules (Advanz) (22/10/2020)
- Medicine Supply Notification - Phytomenadione (Konakion MM Paediatric) 2mg/0.2ml ampoules (Cheplapharm) (22/10/2020)
- Supply issues with Enalapril 20mg tablets
- Medicine supply notification - Sodium cromoglicate (Intal®) CFC-free 5mg inhaler (Sanofi) (08/07/20)
- Medicine supply notification - Ferrous Fumarate 322mg/Folic Acid 350microgram (Pregaday®) tablets (Recipharm) (08/07/20)
- Medicine supply notification - Ranitidine: All formulations update to SDA/2019/005-U2 (30/06/20)
- Medicine supply notification - Mirtazapine 15mg and 45mg orodispersible tablets (30/06/20)
- Medicine supply notification - Lacosamide (Vimpat®) 50mg tablets (30/06/20)
- Medicine supply notification - Lodoxamide 0.1% (Alomide®) eye drops (30/06/20)
- Medicine supply notification - Fluticasone propionate (Flixotide®) 0.5mg/2ml and 2mg/2ml Nebules (30/06/20)
- Medicine supply notification - Imipramine 25mg tablets (30/06/20)
- Vale of York Pharmacy closures and changes of hours - latest position (29/06/20)
- Medicine Supply Notification - Ranitidine: All formulations update to SDA/2019/005-U2 (17/06/20)
- Medicine Supply Notification - Levodopa/carbidopa/entacapone tablets - various brands and strengths (17/06/20)
- Direction of prescriptions (11/06/20)
- Poster on freedom of choice (11/06/20)
- EPS nomination and direction of electronic prescriptions (11/06/20)
- Electronic repeat dispensing letter (05/06/20)
- Serious shortage protocols (SSPs) (21/05/20)
- Drug Alert: Flualprazolam (21/05/20)
- Valproate Pregnancy Prevention Programme (13/05/20)
- MHRA has provided temporary advice for the management of the valproate pregnancy prevention programme during Covid-19. This guidance has also been sent to relevant secondary care colleagues
- Drug Monitoring (13/05/20)
- Please continue to refer to the NHS Specialist Pharmacy Services website regarding guidance/advice on extending the monitoring period of certain medicines. The website was last updated 28.04.2020. A username and password is required to access SPS.
- https://www.sps.nhs.uk/articles/drug-monitoring-in-primary-care-for-stable-patients-during-covid-19/
- Guidance on dealing with patient-returned / unwanted medicines (13/05/20)
- Community Pharmacies have been issued with guidance on how to deal with patient returned medicine
- This is being sent to all Community Pharmacies in North Yorkshire and York (7th May). Recent infection control issues have required changes to the guidance in how this is managed safely. We appreciate GP practices are often asked about this and they should now be able to advise patients with confidence that they can contact their regular Community Pharmacy for this purpose.
- Dispensing doctors may wish to consider this guidance for medicines returned by their dispensing patients.
- Ranitidine, Sulfasalazine oral suspension and Propantheline Shortages
- Please find attached medicines supply notifications. Please read for a summary and actions required.
- Medicine supply notification: Sulfasalazine oral suspension (11/05/20)
- Medicine supply notification: Propantheline (11/05/20)
- Medicine supply notification: Ranitidine - All formulations (11/05/20)
- Vale of York and North Yorkshire CCGs – Guidance on how to obtain urgently required End of Life medicines (07/05/20)
- Using Ferric Maltol instead of intravenous iron treatments in Diagnosed Iron Deficiency Anaemia (IDA) (30/04/20)
- FAO: Prescribers – Re-use of Medicines in a Care Home or Hospice (30/04/20)
- Vale of York Pharmacy closures and changes of hours - latest position (07/05/20)
- Updates from the Regional Drug and Therapeutics Centre (17/04/20)
- Public Health Commissioned Pharmacy Services during the Coronavirus Outbreak - North Yorkshire County Council (17/04/20)
- Using Text/SMS – to Urgently Contact Community Pharmacies (16/04/20)
- Dispensing under regulation 61 (16/04/20)
- BTS Information: Respiratory Inhalers (15/04/20)
- COPD and COVID-19 for Healthcare Professionals (15/04/20)
- RTDC Q&A: Vitamin D and infection risk (15/04/20)
- Important information on prescriptions during the COVID-19 epidemic (09/04/20)
- Accessing palliative care drugs during the COVID-19 Pandemic (09/04/20)
- Covid - Prescribing in diabetes guidance (09/04/20)
- What are the alternative treatment options for patients who normally receive hydroxocobalamin B12 injection during the COVID-19 pandemic (09/04/20)
- Clinical guidelines for symptom control in patients with Covid-19 (08/04/20)
- Options for symptom management in last days if there is no syringe driver or manpower to give injectable drugs (08/04/20)
- NICE Covid-19 information (08/04/20)
- RDTC Covid-19 information and resources (17/04/20)
- Final Guidance on safe switching of warfarin to DOAC (27/03/20)
- Covid-19 Medicines Info from PrescQIPP (19/03/20)
- Advice on ACEi or ARBs (18/03/20)
- Advice on Non-steroidals (18/03/20)
- CMO letter: anti-inflammatory medications (18/03/20)
